REFERENCES
- Bergers G, Javaherian K, Lo K M, Folkman J, Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 1999; 284: 808–12, [PUBMED], [INFOTRIEVE], [CSA]
- Bisacchi D, Benelli R, Vanzetto C, Ferrari N, Tosetti F, Albini A. Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives. Cancer Detect Prev 2003; 27: 229–38, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Black W C, Welch H G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993; 328: 1237–43, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Boehm T, Folkman J, Browder T, O'Reilly M S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404–7, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Browder T, Butterfield C E, Kraling B M, Shi B, Marshall B, O'Reilly M S, Folkman J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60: 1878–86, [PUBMED], [INFOTRIEVE], [CSA]
- Bustos C, Hernandez-Presa M A, Ortego M, Tunon J, Ortega L, Perez F, Diaz C, Hernandez G, Egido J. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol 1998; 32: 2057–64, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cao Y, Cao R. Angiogenesis inhibited by drinking tea. Nature 1999; 398: 381, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Carlile J, Harada K, Baillie R, Macluskey M, Chisholm D M, Ogden G R, Schor S L, Schor A M. Vascular endothelial growth factor (VEGF) expression in oral tissues: possible relevance to angiogenesis, tumour progression and field cancerisation. J Oral Pathol Med 2001; 30: 449–57, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Dell'Aica I, Dona M, Sartor L, Pezzato E, Garbisa S. (-)Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of non-activated MMP-2 at the cell surface. Lab Invest 2002; 82: 1685–93, [PUBMED], [INFOTRIEVE], [CSA]
- Dimitroulakos J, Thai S, Wasfy G H, Hedley D W, Minden M D, Penn L Z. Lovastatin induces a pronounced differentiation response in acute myeloid leukemias. Leuk Lymphoma 2000; 40: 167–78, [PUBMED], [INFOTRIEVE], [CSA]
- Feng C, Ye C, Liu X, Ma H, Li M. beta4 integrin is involved in statin-induced endothelial cell death. Biochem Biophys Res Commun 2004; 323: 858–64, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ferrara N, Hillan K J, Gerber H P, Novotny W. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov 2004; 3: 391–400, Review[PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182–6, [PUBMED], [INFOTRIEVE], [CSA]
- Folkman J. Cancer without disease. Nature 2004; 427: 787, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Garbisa S, Biggin S, Cavallarin N, Sartor L, Benelli R, Albini A. Tumor invasion: molecular shears blunted by green tea. Nat Med 1999; 5: 1216, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Garbisa S, Sartor L, Biggin S, Salvato B, Benelli R, Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 2001; 91: 822–32, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Giavazzi R, Giuliani R, Coltrini D, Bani M, Ferri C, Sennino B, et al. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors. Cancer Res 2001; 61: 309–17, [PUBMED], [INFOTRIEVE], [CSA]
- Hiran T S, Mazurkiewicz J E, Kreienberg P, Rice F L, LaFlamme S E. Endothelial expression of the alpha6beta4 integrin is negatively regulated during angiogenesis. J Cell Sci 2003; 116: 3771–81, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Huss W J, Hanrahan C F, Barrios R J, Simons J W, Greenberg N M. Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Res 2001; 61: 2736–43, [PUBMED], [INFOTRIEVE], [CSA]
- Jimenez B, Volpert O V, Crawford S E, Febbraio M, Silverstein R L, Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6: 41–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jimenez B, Volpert O V. Mechanistic insights on the inhibition of tumor angiogenesis. J Mol Med 2001; 78: 663–72, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lamy S, Gingras D, Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002; 62: 381–5, [PUBMED], [INFOTRIEVE], [CSA]
- Jones M K, Wang H, Peskar B M, Levin E, Itani R M, Sarfeh I J, et al. Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat Med 1999; 5: 1418–23, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jung Y D, Kim M S, Shin B A, Chay K O, Ahn B W, Liu W, et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer 2001; 84: 844–50, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Kawamori T, Rao C V, Seibert K, Reddy B S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 1998; 58: 409–12, [PUBMED], [INFOTRIEVE], [CSA]
- Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer D J, Sessa W C, Walsh K. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000; 6: 1004–10, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Erratum. Nat Med 2001; 7: 129, [CSA], [CROSSREF]
- Lacoste L, Lam J Y, Hung J, Letchacovski G, Solymoss C B, Waters D. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995; 92: 3172–7, [PUBMED], [INFOTRIEVE], [CSA]
- Laufs U, La Fata V, Plutzky J, Liao J K. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 1998; 97: 1129–35, [PUBMED], [INFOTRIEVE], [CSA]
- Lingen M W, Di Pietro L A, Solt D B, Bouck N P, Polverini P J. The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFbeta-1 and is unaffected by ras activation. Carcinogenesis 1997; 18: 329–38, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lippman S M, Hong W K. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys 1989; 17: 691–4, [PUBMED], [INFOTRIEVE], [CSA]
- Liu X H, Kirschenbaum A, Yao S, Lee R, Holland J F, Levine A C. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol 2000; 164: 820–5, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Miao J Y, Araki S, Kaji K, Hayashi H. Integrin beta4 is involved in apoptotic signal transduction in endothelial cells. Biochem Biophys Res Commun 1997; 233: 182–6, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Muller C, Bockhorn A G, Klusmeier S, Kiehl M, Roeder C, Kalthoff H, Koch O M. Lovastatin inhibits proliferation of pancreatic cancer cell lines with mutant as well as with wild-type K-ras oncogene but has different effects on protein phosphorylation and induction of apoptosis. Int J Oncol 1998; 12: 717–23, [PUBMED], [INFOTRIEVE], [CSA]
- Newman A, Clutterbuck R D, Powles R L, Millar J L. Selective inhibition of primary acute myeloid leukaemia cell growth by simvastatin. Leukemia 1994; 8: 2023–9, [PUBMED], [INFOTRIEVE], [CSA]
- Oshima M, Dinchuk J E, Kargman S L, Oshima H, Hancock B, Kwong E, Trzaskos J M, Evans J F, Taketo M M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2(COX-2). Cell 1996; 87: 80–9, [CSA], [CROSSREF]
- Pedersen T R, Wilhelmsen L, Færgeman D, Strandberg T E, Thorgeirsson G, Troedsson L, Kristianson J, Berg K, Cook T J, Haghfelt T, Kjekshus J, Miettinen T, Olsson A G, Pyörälä K, Wedel H. On behalf of the Scandinavian Simvastatin Survival Study Group. A follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol lowering. The American Journal of Cardiology 2000; 86: 257–262, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Perez-Sala D, Mollinedo F. Inhibition of isoprenoid biosynthesis induces apoptosis in human promyelocytic HL-60 cells. Biochem Biophys Res Commun 1994; 199: 1209–15, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ravid T, Avner R, Polak-Charcon S, Faust J R, Roitelman J. Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation in lovastatin-resistant cells. J Biol Chem 1999; 274: 29341–51, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Sandler A B, Johnson D H, Herbst R S. Anti-vascular endothelial growth factor monoclonals in non-small cell lung cancer. Clin Cancer Res 2004; 10: 4258s–4262s, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tosetti F, Ferrari N, De Flora S, Albini A. Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 2002; 16: 2–14, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Tran J, Master Z, Yu J L, Rak J, Dumont D J, Kerbel R S. A role for survivin in chemoresistance of endothelial cells mediated by VEGF. Proc Natl Acad Sci USA 2002; 99: 4349–54, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Urbich C, Dernbach E, Zeiher A M, Dimmeler S. Double-edged role of statins in angiogenesis signaling. Circ Res 2002; 90: 737–44, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Vincent L, Chen W, Hong L, Mirshahi F, Mishal Z, Mirshahi-Khorassani T, Vannier J P, Soria J, Soria C. Inhibition of endothelial cell migration by cerivastatin, an HMG-CoA reductase inhibitor: contribution to its anti-angiogenic effect. FEBS Lett 2001; 495: 159–66, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Volpert O V. Modulation of endothelial cell survival by an inhibitor of angiogenesis thrombospondin-1: a dynamic balance. Cancer Metastasis Rev 2000; 19: 87–92, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Volpert O V, Zaichuk T, Zhou W, Reiher F, Ferguson T A, Stuart P M, Amin M, Bouck N P. Inducer-stimulated Fas targets activated endothelium for destruction by anti-angiogenic thrombospondin-1 and pigment epithelium-derived factor. Nat Med 2002; 8: 349–57, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Weis M, Heeschen C, Glassford A J, Cooke J P. Statins have biphasic effects on angiogenesis. Circulation 2002; 105: 739–45, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wong W W, Dimitroulakos J, Minden M D, Penn L Z. HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 2002; 16: 508–19, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zondor S D, Medina P J. Bevacizumab: an angiogenesis inhibitor with efficacy in colorectal and other malignancies. Ann Pharmacother 2004; 38: 1258–64, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]